PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 26, 2025International Journal of Molecular Sciences0 citationsOpen Access

Exosomal miRNAs: Key Regulators of the Tumor Microenvironment and Cancer Stem Cells

View Full Paper
SWShuangmin WangSJShi JinJZJidong Zhang

Key Points

  • Exosomal miRNAs promote tumor progression, enhancing cancer stem cells and immune evasion mechanisms.
  • They modulate immune cells and fibroblasts, significantly impacting processes like angiogenesis and epithelial–mesenchymal transition.
  • The review highlights exosomal miRNAs' role as potential biomarkers and therapeutic targets in cancer treatment.
  • Overall, they serve as critical regulators of malignant progression, emphasizing their importance in cancer research.

Abstract

Exosomes are lipid bilayer vesicles approximately 30–150 nm in diameter that serve as key mediators of intercellular communication. By transporting diverse bioactive molecules, including proteins and nucleic acids, they play a crucial role in tumor initiation and progression. Among their functional cargo, exosomal microRNAs (miRNAs) are central to epigenetic regulation and intercellular signaling, significantly influencing tumor biology. This review provides a comprehensive overview of the multifaceted roles of exosomal miRNAs in remodeling the tumor microenvironment (TME) and regulating cancer stem cells (CSCs). Specifically, exosomal miRNAs modulate various immune cells (such as macrophages, T cells, and NK cells) as well as cancer-associated fibroblasts (CAFs), thereby promoting immune evasion, angiogenesis, epithelial–mesenchymal transition (EMT), and metastatic progression. At the same time, they enhance CSC stemness, self-renewal, and therapeutic resistance, ultimately driving tumor recurrence and dissemination. Furthermore, exosome-mediated miRNA signaling acts as a critical force in malignant progression. Finally, we discuss the clinical potential of exosomal miRNAs as diagnostic and prognostic biomarkers, therapeutic targets, and vehicles for targeted drug delivery, highlighting their translational value and future directions in cancer research.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/68d6c687b1249cec298b2aa3https://doi.org/10.3390/ijms26199323
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity2020 · 91 citations
  2. 2Macrophage-secreted Exosomes Delivering miRNA-21 Inhibitor can Regulate BGC-823 Cell Proliferation2015 · 69 citations
  3. 3miR-155 in cancer drug resistance and as target for miRNA-based therapeutics2017 · 226 citations
  4. 4Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity2012 · 174 citations
  5. 5Identification of CD200+ colorectal cancer stem cells and their gene expression profile2016 · 30 citations